Tuesday, November 06, 2007 11:32:42 AM
Otherwise, you risk another "Ready-Fire-Aim" exercise in the PII's. Considering that the Panzem capsules/NCD episode may ultimately prove to be the reason PZ isn't already a billion dollar drug like Revlimid by now, I think we want them to get things right before they spend a lot of money for human trials.
A partner for injections isn't a dumb idea, but I would speculate that the need for that depends on the serum concentrations they're currently getting and how close the company really is to significant good news from the current trials.
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM